As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became very good at it.
Kiran Mazumdar-ShawMy legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.
Kiran Mazumdar-ShawOne of my objectives when I started Biocon was to make sure that I create a company for women scientists to pursue a vocation.
Kiran Mazumdar-Shaw